Literature DB >> 35701567

Evidence synthesis practice: why we cannot ignore studies with no events?

Chang Xu1, Lifeng Lin2, Sunita Vohra3,4.   

Abstract

Entities:  

Year:  2022        PMID： 35701567      PMCID： PMC9585115          DOI： 10.1007/s11606-022-07696-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  6 in total

1.  A proposed framework to guide evidence synthesis practice for meta-analysis with zero-events studies.

Authors:  Chang Xu; Luis Furuya-Kanamori; Liliane Zorzela; Lifeng Lin; Sunita Vohra
Journal:  J Clin Epidemiol       Date:  2021-02-13       Impact factor: 6.437

2.  The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses.

Authors:  Ignacio Atal; Raphaël Porcher; Isabelle Boutron; Philippe Ravaud
Journal:  J Clin Epidemiol       Date:  2019-03-30       Impact factor: 6.437

3.  Exclusion of studies with no events in both arms in meta-analysis impacted the conclusions.

Authors:  Chang Xu; Ling Li; Lifeng Lin; Haitao Chu; Lehana Thabane; Kang Zou; Xin Sun
Journal:  J Clin Epidemiol       Date:  2020-04-01       Impact factor: 6.437

4.  Synthesis of evidence from zero-events studies: A comparison of one-stage framework methods.

Authors:  Chang Xu; Luis Furuya-Kanamori; Lifeng Lin
Journal:  Res Synth Methods       Date:  2021-08-20       Impact factor: 5.273

5.  Validity of data extraction in evidence synthesis practice of adverse events: reproducibility study.

Authors:  Chang Xu; Tianqi Yu; Luis Furuya-Kanamori; Lifeng Lin; Liliane Zorzela; Xiaoqin Zhou; Hanming Dai; Yoon Loke; Sunita Vohra
Journal:  BMJ       Date:  2022-05-10

6.  Utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation.

Authors:  Chang Xu; Xiaoqin Zhou; Liliane Zorzela; Ke Ju; Luis Furuya-Kanamori; Lifeng Lin; Cuncun Lu; Omran A H Musa; Sunita Vohra
Journal:  BMC Med       Date:  2021-06-15       Impact factor: 8.775
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.